JP2023543254A5 - - Google Patents

Info

Publication number
JP2023543254A5
JP2023543254A5 JP2023519165A JP2023519165A JP2023543254A5 JP 2023543254 A5 JP2023543254 A5 JP 2023543254A5 JP 2023519165 A JP2023519165 A JP 2023519165A JP 2023519165 A JP2023519165 A JP 2023519165A JP 2023543254 A5 JP2023543254 A5 JP 2023543254A5
Authority
JP
Japan
Prior art keywords
substituted
pharmaceutically acceptable
solvate
unsubstituted
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023519165A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023543254A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/051670 external-priority patent/WO2022066851A1/en
Publication of JP2023543254A publication Critical patent/JP2023543254A/ja
Publication of JP2023543254A5 publication Critical patent/JP2023543254A5/ja
Pending legal-status Critical Current

Links

JP2023519165A 2020-09-24 2021-09-23 ピリド[4,3-b]インドール誘導体およびその医薬としての使用 Pending JP2023543254A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063082695P 2020-09-24 2020-09-24
US63/082,695 2020-09-24
PCT/US2021/051670 WO2022066851A1 (en) 2020-09-24 2021-09-23 PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

Publications (2)

Publication Number Publication Date
JP2023543254A JP2023543254A (ja) 2023-10-13
JP2023543254A5 true JP2023543254A5 (cg-RX-API-DMAC7.html) 2024-10-01

Family

ID=80846865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023519165A Pending JP2023543254A (ja) 2020-09-24 2021-09-23 ピリド[4,3-b]インドール誘導体およびその医薬としての使用

Country Status (7)

Country Link
US (1) US20240018138A1 (cg-RX-API-DMAC7.html)
EP (1) EP4216940A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023543254A (cg-RX-API-DMAC7.html)
CN (1) CN116209442A (cg-RX-API-DMAC7.html)
AU (1) AU2021349249A1 (cg-RX-API-DMAC7.html)
CA (1) CA3196153A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022066851A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230124665A (ko) 2020-12-22 2023-08-25 노파르티스 아게 Cgas 관련 병태의 치료에 유용한 인돌 유도체
WO2023183275A1 (en) * 2022-03-22 2023-09-28 Ventus Therapeutics U.S., Inc. Hexahydropyrido[4,3-b]indolyl ketone derivatives useful as cgas modulators
CN121248633A (zh) * 2022-11-09 2026-01-02 勃林格殷格翰国际有限公司 作为cGAS抑制剂的环状苯并咪唑衍生物
CN120769854A (zh) * 2022-12-21 2025-10-10 伊莱利利公司 氮杂䓬并[4,5-B]吲哚酮cGAS抑制剂
AR133584A1 (es) 2023-08-18 2025-10-15 Univ Leuven Kath Nuevos compuestos
CN119490508A (zh) * 2023-08-21 2025-02-21 上海交通大学 一类螺环四氢-γ-咔啉衍生物的制备方法以及应用
WO2025218659A1 (en) * 2024-04-16 2025-10-23 Insilico Medicine Ip Limited Novel compounds as cyclic gmp-amp synthase inhibitor and uses thereof
WO2026026969A1 (zh) * 2024-08-01 2026-02-05 杭州英创医药科技有限公司 作为cGAS抑制剂的化合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011019417A1 (en) * 2009-04-29 2011-02-17 Medivation Technologies, Inc. Pyrido [4, 3-b] indoles and methods of use
CN109311876B (zh) * 2016-06-16 2022-05-03 豪夫迈·罗氏有限公司 杂芳基雌激素受体调节剂及其用途
JP2021506862A (ja) * 2017-12-19 2021-02-22 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Tlr7/8アンタゴニストおよびそれらの使用
MX2020008237A (es) * 2018-02-05 2020-09-25 Univ Rockefeller Inhibidores de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol de cgas para tratar enfermedades autoinflamatorias.
WO2020142729A1 (en) * 2019-01-04 2020-07-09 BellBrook Labs Inhibitors of cgas activity as therapeutic agents
WO2020186027A1 (en) * 2019-03-13 2020-09-17 Daisuke Tomita Inhibitors of cgas for treating autoinflammatory diseases and cancer metastasis

Similar Documents

Publication Publication Date Title
JP2022512482A5 (cg-RX-API-DMAC7.html)
JP2024050527A5 (cg-RX-API-DMAC7.html)
JP2024514837A5 (cg-RX-API-DMAC7.html)
JP2024529070A5 (cg-RX-API-DMAC7.html)
JP2024520481A5 (cg-RX-API-DMAC7.html)
JP2021535207A5 (cg-RX-API-DMAC7.html)
JP2020521766A5 (cg-RX-API-DMAC7.html)
JP2022505987A5 (cg-RX-API-DMAC7.html)
JP2024509818A5 (cg-RX-API-DMAC7.html)
JP2024512154A5 (cg-RX-API-DMAC7.html)
RU2019100164A (ru) Гетероциклическое соединение, используемое как ингибитор fgfr
JP2010506854A5 (cg-RX-API-DMAC7.html)
JP2023531709A5 (cg-RX-API-DMAC7.html)
JP2018504437A5 (cg-RX-API-DMAC7.html)
JP2023526625A5 (cg-RX-API-DMAC7.html)
JP2023552610A5 (cg-RX-API-DMAC7.html)
JP2010540508A5 (cg-RX-API-DMAC7.html)
JP2014503574A5 (cg-RX-API-DMAC7.html)
JP2022533069A5 (cg-RX-API-DMAC7.html)
JP2023533203A5 (cg-RX-API-DMAC7.html)
AR076024A1 (es) Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
JP2019530724A5 (cg-RX-API-DMAC7.html)
JP2017531013A5 (cg-RX-API-DMAC7.html)
JP2014514290A5 (cg-RX-API-DMAC7.html)
JP2021528451A5 (cg-RX-API-DMAC7.html)